Covid Report: Overtaxed, Gilead Suspends Access To Coronavirus Drug

This post was originally published on this siteGilead Sciences (GILD) says its overtaxed system can no longer fulfill most compassionate-use requests for experimental coronavirus treatment,

Read More

Covid-19 Report: Why It Could Be A Year Before We Have A Coronavirus Vaccine

This post was originally published on this siteExperts say it will be at least a year before the Food and Drug Administration approves a coronavirus vaccine. X. Error loading player: No playable

Read More

Oil’s Freefall Halted By Hope OPEC And Allies Will Take Action

This post was originally published on this siteExpectations the OPEC+ alliance will deepen output cuts put a floor under last week’s 16% plunge in oil prices, with futures in New York

Read More

Coronavirus Infects Wall Street — Can Gilead, Moderna Ride To The Rescue?

This post was originally published on this siteAs fears of a global Covid-19 pandemic pummel the stock market, biotech companies like Moderna (MRNA) and Gilead Sciences (GILD) are scrambling to

Read More

A Rumored Gilead Takeover Offer Sent This Biotech Stock Flying

This post was originally published on this siteShares of Forty Seven (FTSV) popped late Thursday on a report Gilead Sciences (GILD) approached the cancer-focused biotech company with a takeover

Read More

Salesforce Earnings Top Estimates, Stock Falls As Co-CEO Steps Down

This post was originally published on this siteSalesforce.com (CRM) earnings for the fourth quarter fell from a year earlier but topped estimates while the company announced Keith Block will step

Read More

Company Profit Warnings Signal Virus Already a Global Crisis

This post was originally published on this siteFor big business, the impact of the new coronavirus epidemic is exacting a growing toll worldwide. X. Error loading player: No playable sources

Read More

Gilead Stock Pops To 16-Month High As It Nears Key Approval In China

This post was originally published on this siteChinese officials accepted the application for Gilead Sciences’ (GILD) cancer drug Yescarta on Monday — prodding GILD stock to jump amid

Read More

AstraZeneca Earnings Mixed; Drug Giant Rises Slightly

This post was originally published on this siteEarly Friday, AstraZeneca reported core earnings of 89 cents per share on $6.66 billion in sales for its fourth quarter. In response, AZN stock rose

Read More

Why Drug Giant Teva Pharma Just Rocketed Into A Profit-Taking Zone

This post was originally published on this siteTeva Pharmaceutical (TEVA) easily beat fourth-quarter expectations Wednesday, sending Teva stock rocketing to a nine-month high. X. Error loading

Read More